Literature DB >> 27162213

Is There a Relationship of Operator and Center Volume With Access Site-Related Outcomes? An Analysis From the British Cardiovascular Intervention Society.

William Hulme1, Matthew Sperrin1, Helen Rushton1, Peter F Ludman1, Mark De Belder1, Nick Curzen1, Tim Kinnaird1, Chun Shing Kwok1, Iain Buchan1, James Nolan1, Mamas A Mamas2.   

Abstract

BACKGROUND: Transradial access is associated with reduced access site-related bleeding complications and mortality post percutaneous coronary intervention. The objective of this study is to examine the relationship between access site practice and clinical outcomes and how this may be influenced by operator and center experience/expertise. METHODS AND
RESULTS: The influence of operator and center experience/expertise was studied on 30-day mortality, in-hospital major adverse cardiovascular events (a composite of in-hospital mortality and in-hospital myocardial infarction and target vessel revascularization) and in-hospital major bleeding based on access site adopted (radial versus femoral). Operator/center experience/expertise were defined by both total volume and transradial access proportion. A total of 164 395 procedures between 2012 and 2013 in the National Health Service in England and Wales were analyzed. After case-mix adjustment, transradial access was associated with an average odds reduction of 39% for 30-day mortality compared with transfemoral access (odds ratio, 0.61; 95% confidence interval, 0.55-0.68; P<0.001). The magnitude of this risk reduction was modified by increases in total procedural volume and radial proportion at the operator level (odds ratio reduction of 11% per 100 extra procedures, 95% confidence interval, 3%-19%; odds ratio reduction of 6% per 10%-point increase in radial proportion, 95% confidence interval, 1%-11%) with no significant impact of operator radial volume, center total volume, center radial volume, and center radial proportion.
CONCLUSIONS: The lower mortality associated with transradial access adoption relates to both the total procedural volume and the proportion of procedures undertaken radially by operator, with operators undertaking the greatest proportion of their procedures radially having the largest relative reduction in mortality risk.
© 2016 American Heart Association, Inc.

Entities:  

Keywords:  hemorrhage; mortality; myocardial infarction; percutaneous coronary intervention; risk reduction

Mesh:

Year:  2016        PMID: 27162213     DOI: 10.1161/CIRCINTERVENTIONS.115.003333

Source DB:  PubMed          Journal:  Circ Cardiovasc Interv        ISSN: 1941-7640            Impact factor:   6.546


  4 in total

1.  Transradial versus transfemoral approach for percutaneous coronary intervention in patients with ST-elevation myocardial infarction complicated by cardiogenic shock: a systematic review and meta-analysis.

Authors:  Muhammad Junaid Ahsan; Soban Ahmad; Azka Latif; Noman Lateef; Mohammad Zoraiz Ahsan; Waiel Abusnina; Sandeep Nathan; S Elissa Altin; Dhaval S Kolte; John C Messenger; Mark Tannenbaum; Andrew M Goldsweig
Journal:  Eur Heart J Qual Care Clin Outcomes       Date:  2022-09-05

2.  Stent and Dual Antiplatelet Therapy Duration Comparisons in the Setting of a Multicenter Randomized Controlled Trial: Can the Operator Experience Affect the Study Results?

Authors:  Giuseppe Gargiulo; Dik Heg; Fabrizio Ferrari; Gianfranco Percoco; Gianluca Campo; Carlo Tumscitz; Federico Colombo; Andrea Zuffi; Fausto Castriota; Alberto Cremonesi; Stephan Windecker; Marco Valgimigli
Journal:  J Am Heart Assoc       Date:  2017-12-23       Impact factor: 5.501

3.  Hand dysfunction after transradial artery catheterization for coronary procedures.

Authors:  Muhammad Ayyaz Ul Haq; Muhammad Rashid; Chun Shing Kwok; Chun Wai Wong; James Nolan; Mamas A Mamas
Journal:  World J Cardiol       Date:  2017-07-26

4.  Alternative access site choice after initial radial access site failure for coronary angiography and intervention.

Authors:  Dionysios Gatzopoulos; Aggeliki Rigatou; Eleftherios Kontopodis; Ioannis Tsiafoutis; Maria Agelaki; Efstathios Lazaris; Konstantinos Kintis; Sotirios Patsilinakos; Michael Koutouzis
Journal:  J Geriatr Cardiol       Date:  2018-09-28       Impact factor: 3.327

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.